Jonathan Mark Hopper
CIK 1626325 · Chief Medical Officer · last filed 2026-06-04
Jonathan Mark Hopper is a Chief Medical Officer who has filed 46 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for VCEL, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$6.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.71M
2
46
-$6.26M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Chief Medical Officer | 80,128 | $46.24 | $3.71M | -$6.26M | 33 | 2026-06-04 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2016-04-15 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | VCEL | Notice (144) | −10,000 | -$450.0K | EDGAR |
| 2026-06-04 | VCEL | Mixed | — | -$80.2K | EDGAR |
| 2026-06-02 | VCEL | Notice (144) | −4,375 | -$153.1K | EDGAR |
| 2026-04-06 | VCEL | Mixed | — | -$83.5K | EDGAR |
| 2026-04-02 | VCEL | Notice (144) | −3,472 | -$121.5K | EDGAR |
| 2026-02-26 | VCEL | Mixed | +4,529 | -$75.2K | EDGAR |
| 2026-02-20 | VCEL | Mixed | +4,343 | -$36.7K | EDGAR |
| 2025-12-04 | VCEL | Mixed | — | -$34.9K | EDGAR |
| 2025-12-02 | VCEL | Notice (144) | −1,652 | -$64.7K | EDGAR |
| 2025-09-03 | VCEL | Mixed | — | -$177.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.